The problem of osteoporosis in general medical practice: prevalence, risk factors, genetic predictors. Role of chronic pancreatitis and hypertensive disease in the formation of secondary osteoporosis.

PhD T. Viun, PhD S. Viun, PhD A. Andrusha, as. A. Marchenko

Kharkiv National Medical University

The combination of socially significant common chronic non-infectious diseases of internal organs, the interaction of their pathogenetic links quite often leads to the development of complications that affect the course of the main nosology. Among these tandems, chronic pancreatitis and hypertension are considered — calcium-dependent diseases, the comorbidity of which can affect the disturbances in calcium metabolism, thereby contributing to the formation of osteopenic conditions. A number of researchers have established that the development of diseases such as chronic pancreatitis and hypertension, and their complications (namely, osteoporosis) can be the result of the presence of candidate genes, the unfavorable polymorphism of which can provoke changes in the pathogenetic directions of the diseases course.

https://dx.doi.org/10.15407/internalmed2021.01.121

Download.PDF (rus)

Cite:

1. Вьюн, Т.И., Вьюн, С.В., Андруша, А.Б., Марченко, А.С. Проблема остеопороза в общеврачебной практике: распространенность, факторы риска, генетические предикторы. Роль хронического панкреатита и гипертонической болезни в формирование вторичного остеопороза // Східноєвропейський журнал внутрішньої та сімейної медицини. – 2021. – №1. – С. 121-126. doi: 10.15407/internalmed2021.01.121

2. Viun TI, Viun SV, Andrusha AB, Marchenko AS. [The problem of osteoporosis in general medical practice: prevalence, risk factors, genetic predictors. Role of chronic pancreatitis and hypertensive disease in the formation of secondary osteoporosis]. Shidnoevr. z. vnutr. simejnoi med. 2021;1:121-126. Russian. doi: 10.15407/internalmed2021.01.121

References:

1. Viun TI, Lazutkina OA. Sposib diahnostyky osteoporotychnykh staniv u khvorykh na khronichnyi pankreatyt poiednanoho z hipertonichnoiu khvoroboiu. V: Pasiieshvili LM, red. Universytetska klinika. Multymorbidnist i komorbidnist u poliprofilnii likarni. Materialy nauk.-prakt. konf. z mizhnar. uchastiu; 2019 berez. 14; Kharkiv, Ukraina. Kharkiv: Styl-Izdat; 2019. Р 28-30. Ukrainian.

2. Johnell O, Kanis J, Odén A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, Jönsson B. Mortality after osteoporotic fractures. Osteoporosis International. 2003;15(1):38-42. http://dx.doi.org/10.1007/s00198-003-1490-4
https://doi.org/10.1007/s00198-003-1490-4

3. Benevolenskaja LI. Rukovodstvo po osteoporozu. Moskva: Binom; 2013. Р 91;261-88;320-46. Russian

4. Luz Villa M, Nelson L. Race. Ethnicity, and osteoporosis. In: Marcus R, Feldman D, Kelsey J. Osteoporosis. San Diego: Academic Press. 2016;:435-48.

5. Melton L. Differing patterns of osteoporosis across the world. In: Chesnut C. New dimensions in osteoporosis in the 1990s. Hong Kong: Excerpta Medica Asia. 2019;:13- 18.

6. . 6. Sinjachenko OV, Ermolaeva MV, Gejko IA, Taktashov GS, Jutovec TS. Rol’ kostnogo metabolizma v patogeneze gonartroza . Origіnal’nі doslіdzhennja. 2016;17(1):67-70. Russian

7. Viun TI. Diagnosis of osteoporotic conditions in patients with combined course of chronic pancreatitis and hypertensive disease by determination of tartrate-resistant acid phosphatase // Juvіlejnі terapevtichnі chitannja. Klіnіchna ta profіlaktichna medicina: dosvіd ta novі naprjamki rozvitku. Materіali nauk.-prakt. konf. z mіzhnar. uchastju, prisvjach. 100-rіchchju vіd dnja narodzh. akad. LT. Maloy; 11-12 kvіtnja 2019. Harkіv. 2019. Р 301. Ukrainian

8. Malichenko SB, Kolosova IR. Profilaktika i lechenie pervichnogo osteoporoza u lic starshego vozrasta. Spravochnik poliklinicheskogo vracha. 2015;3(2):44-7. Russian

9. Benevolenskaja L.I, Mihajlov E.E, Toropcova N.V. Problema osteoporoza v sovremennom mire // Russ. med. zhurnal.- 2015;24:1582-5. Russian

10. Pasiieshvili LM, Tereshkin KI. Rol vyznachennia henetychnykh markeriv ta rivnia apelina u khvorykh na osteoartroz na tli ozhyrinnia v klinichnii praktytsi. Khronichni neinfektsiini zakhvoriuvannia: zakhody profilaktyky i borotby z uskladnenniamy. Materialy nauk.-prakt. konf. z mizhnar. uchastiu; 2015 lystopadu. 5; Kharkiv, 2015. Р 210. Ukrainian

11. Tereshkin KI. Prohnostychno-diahnostychne znachennia apelinu-13 ta polimorfizmu heniv VDR, LCT ta FDPS v rozvytku osteoartrozu na tli ozhyrinnia u osib molodoho viku [dysertatsiia] Kharkiv: Khark. nats. med. un-t; 2017. Ukrainian

12. Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey E, Jönsson B, Kanis J. Osteoporosis in the European Union: medical management, epidemiology and economic burden. Archives of Osteoporosis. 2013;8(1-2):136. http://dx.doi.org/10.1007/s11657-013-0136-1
https://doi.org/10.1007/s11657-013-0136-1

13. Povoroznyuk V, Grygorieva N, Kanis J, EV M, Johansson H, Harvey N, Korzh M, Strafun S, Vaida V, Klymovytsky F, Vlasenko R, Forosenko V. Epidemiology of hip fracture and the development of FRAX in Ukraine. Archives of Osteoporosis. 2017;12(1):53. http://dx.doi.org/10.1007/s11657-017-0343-2
https://doi.org/10.1007/s11657-017-0343-2

14. Compston J, McClung M, Leslie W. Osteoporosis. The Lancet. 2019;393(10169):364-376. http://dx.doi.org/10.1016/s0140-6736(18)32112-3
https://doi.org/10.1016/S0140-6736(18)32112-3

15. Cosman F, de Beur S, LeBoff M, Lewiecki E, Tanner B, Randall S, Lindsay R. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporosis International. 2014;25(10):2359-2381. http://dx.doi.org/10.1007/s00198-014-2794-2
https://doi.org/10.1007/s00198-014-2794-2

16. Siris E, Adler R, Bilezikian J, Bolognese M, Dawson-Hughes B, Favus M, Harris S, Jan de Beur S, Khosla S, Lane N, Lindsay R, Nana A, Orwoll E, Saag K, Silverman S, Watts N. The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporosis International. 2014;25(5):1439-1443. http://dx.doi.org/10.1007/s00198-014-2655-z
https://doi.org/10.1007/s00198-014-2655-z

17. Ström O, Borgström F, Kanis J, Compston J, Cooper C, McCloskey E, Jönsson B. Osteoporosis: burden, health care provision and opportunities in the EU. Archives of Osteoporosis. 2011;6(1-2):59-155. http://dx.doi.org/10.1007/s11657-011-0060-1
https://doi.org/10.1007/s11657-011-0060-1

18. Fujita T. Osteoporosis: Past, present and future. Osteoporosis International. 1997;7(S3):6-9. http://dx.doi.org/10.1007/bf03194335
https://doi.org/10.1007/BF03194335

19. Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey E, Jönsson B, Kanis J. Osteoporosis in the European Union: medical management, epidemiology and economic burden. Archives of Osteoporosis. 2013;8(1-2):136. http://dx.doi.org/10.1007/s11657-013-0136-1
https://doi.org/10.1007/s11657-013-0136-1

20. Jeremiah M, Unwin B, Greenawald M, Casiano V. Diagnosis and Management of Osteoporosis. Am Fam Physician. 2015;92:261-268.

21. Duggan S, Purcell C, Kilbane M, O’Keane M, McKenna M, Gaffney P, Ridgway P, Boran G, Conlon K. An Association Between Abnormal Bone Turnover, Systemic Inflammation, and Osteoporosis in Patients With Chronic Pancreatitis: A Case-Matched Study. American Journal of Gastroenterology. 2015;110(2):336-345. http://dx.doi.org/10.1038/ajg.2014.430
https://doi.org/10.1038/ajg.2014.430

22. Pasieshvili L, Viun T, Viun S. Biochemical and genetic characteristics of secondary osteoporosis in patients with combined course of chronic pancreatitis and hypertensive disease. The scientific heritage. 2019;40(2):35-41.

23. Olmos J, Zarrabeitia M, Hernández J, Sañudo C, González-Macías J, Riancho J. Common allelic variants of the farnesyl diphosphate synthase gene influence the response of osteoporotic women to bisphosphonates. The Pharmacogenomics Journal. 2010;12(3):227-232. http://dx.doi.org/10.1038/tpj.2010.88
https://doi.org/10.1038/tpj.2010.88

24. Haussler M, Whitfield G, Kaneko I, Haussler C, Hsieh D, Hsieh J, Jurutka P. Molecular Mechanisms of Vitamin D Action. Calcified Tissue International. 2012;92(2):77-98. http://dx.doi.org/10.1007/s00223-012-9619-0
https://doi.org/10.1007/s00223-012-9619-0

25. Tereshkin KI. Osteoartroz u patsiientiv z variantamy polimorfizmu hena retseptora vitaminu D. Svit medytsyny ta biolohii. 2016;3(1):74-80. Ukrainian

26. Pasiieshvili LM, Viun TI. Vplyv polimorfizmu hena retseptoriv vitamina D na vyraznist osteopenichnoho syndromu u patsiientiv na khronichnyi pankreatyt z suputnoiu hipertonichnoiu khvoroboiu. Ukr. zhurn. medytsyny, biolohii ta sportu. 2018;3(2):114-9. doi: 10.26693/jmbs03.02.114. Ukrainian
https://doi.org/10.26693/jmbs03.02.114

27. Povorozniuk VV, Pludovski P, red. Defitsyt ta nedostatnist vitaminu D: epidemiolohiia, diahnostyka, profilaktyka ta likuvannia. Donetsk: Zaslavskyi AIu; 2014. Ukrainian

28. Liu Y, Liu H, Li M, Zhou P, Xing X, Xia W. Association of farnesyl diphosphate synthase polymorphisms and response to alendronate treatment in Chinese postmenopausal women with osteoporosis. Chin Med J (Engl). 2014;127(4):662-8. doi:10.3760/cma.j.issn.0366- 6999.20132382.

29. Levy M, Parker R, Ferrell R, Zmuda J, Greenspan S. Farnesyl diphosphate synthase: A novel genotype association with bone mineral density in elderly women. Maturitas. 2007;57(3):247-252. http://dx.doi.org/10.1016/j.maturitas.2007.01.005
https://doi.org/10.1016/j.maturitas.2007.01.005

30. V’jun TI, Pasieshvili LM. Diagnosticheskaja rol’ biohimicheskih markerov kostnogo metabolizma i gena FDPS v ocenke vtorichnogo osteoporoza u pacientov s hronicheskim pankreatitom i gipertonicheskoj bolezn’ju. Nauka i zdravoohranenie (Kazahstan). 2018;4(20):5-21. Russian

31. Manohar M, Verma A, Venkateshaiah S, Sanders N, Mishra A. Pathogenic mechanisms of pancreatitis. World Journal of Gastrointestinal Pharmacology and Therapeutics. 2017;8(1):10. http://dx.doi.org/10.4292/wjgpt.v8.i1.10
https://doi.org/10.4292/wjgpt.v8.i1.10

32. Olmos J, Zarrabeitia M, Hernández J, Sañudo C, González-Macías J, Riancho J. Common allelic variants of the farnesyl diphosphate synthase gene influence the response of osteoporotic women to bisphosphonates. The Pharmacogenomics Journal. 2010;12(3):227-232. http://dx.doi.org/10.1038/tpj.2010.88
https://doi.org/10.1038/tpj.2010.88

33. Olds L. Lactase persistence DNA variant enhances lactase promoter activity in vitro: functional role as a cis regulatory element. Human Molecular Genetics. 2003;12(18):2333-2340. http://dx.doi.org/10.1093/hmg/ddg244
https://doi.org/10.1093/hmg/ddg244

34. Viun T. GENETIC DETERMINANTS OF OSTEOPOROTIC RISK IN CALCIUM-DEPENDENT DISEASES – CHRONIC PANCREATITIS AND HYPERTENSIVE DISEASE.. Inter Collegas. 2019;6(1):43-49. http://dx.doi.org/10.35339/ic.6.1.43-49
https://doi.org/10.35339/ic.6.1.43-49

35. Clark G, Duncan E. The genetics of osteoporosis. British Medical Bulletin. 2015;113(1):73-81. http://dx.doi.org/10.1093/bmb/ldu042
https://doi.org/10.1093/bmb/ldu042

36. Viun T, Pasieshvili L. Pathogenetic links of the combined course of chronic pancreatitis and hypertensive disease and their role in the formation of complications. Georgian Medical News. 2018;10(283):81-4.

37. Mattar R, Mazo, Carrilho. Lactose intolerance: diagnosis, genetic, and clinical factors. Clinical and Experimental Gastroenterology. 2012;5:113. http://dx.doi.org/10.2147/ceg.s32368
https://doi.org/10.2147/CEG.S32368

38. Eremina EA, Kucher AN. Geneticheskie faktory, predraspolagajushhie k razvitiju mnogofaktornyh zabolevanij u predstavitelej dvuh jetnicheskih grupp Respubliki Burjatija. Cib. med. zhurn. 2017;107(8):8-12. Russian

39. Pasiieshvili LM, Viun TI. Vzaiemozviazok polimorfizmu hena laktazy z perebihom khronichnoho pankreatytu u patsiientiv z hipertonichnoiu khvoroboiu. Suchasna hastroenterolohiia. 2018;1(99):20-6. Ukrainian